Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Teriflunomide”

Showing 20 of 0 results

Not applicableUnknownNCT05075499
What this trial is testing

Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab

Who this might be right for
Multiple Sclerosis
Sheba Medical Center 70
Large-scale testing (Phase 3)Active Not RecruitingNCT04586010
What this trial is testing

Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Multiple Sclerosis
Hoffmann-La Roche 746
Not applicableStudy completedNCT02679885
What this trial is testing

Teriflunomide Male Transmission Study

Who this might be right for
Multiple Sclerosis
Griffin Hospital 20
Post-approval studies (Phase 4)Study completedNCT01970410
What this trial is testing

MAIN STUDY: SWITCH SUB-STUDY: SWITCH-JCV

Who this might be right for
Multiple Sclerosis
Providence Health & Services 55
Large-scale testing (Phase 3)Study completedNCT04788615
What this trial is testing

Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)Looking for participantsNCT04799288
What this trial is testing

Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis

Who this might be right for
HAM/TSP
National Institute of Neurological Disorders and Stroke (NINDS) 24
Large-scale testing (Phase 3)Study completedNCT02792218
What this trial is testing

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 930
Large-scale testing (Phase 3)Study completedNCT05385744
What this trial is testing

An International, Multicenter, Randomized, Double-Blind, Double-Masked Study of the Efficacy and Safety of BCD-132 (JSC BIOCAD, Russia) Using an Active Reference Drug (Teriflunomide) for the Treatment of Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Biocad 336
Post-approval studies (Phase 4)Study completedNCT04410965
What this trial is testing

Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese RMS Patients Treated With Teriflunomide 14 mg Once Daily for 24 Weeks

Who this might be right for
Multiple Sclerosis
Sanofi 82
Not applicableLooking for participantsNCT05344469
What this trial is testing

A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 800
Post-approval studies (Phase 4)Study completedNCT04129736
What this trial is testing

Teriflunomide Concentration in Serum and Cerebrospinal Fluid From Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Pharmacokinetics
Jan Lycke 12
Large-scale testing (Phase 3)Study completedNCT01863888
What this trial is testing

Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 70
Testing effectiveness (Phase 2)Study completedNCT03709446
What this trial is testing

Leflunomide in Previously Treated Metastatic Triple Negative Cancers

Who this might be right for
Breast NeoplasmsBreast DiseasesMetastatic Triple Negative Breast Cancer
Joseph Sparano 17
Not applicableStudy completedNCT02776072
What this trial is testing

Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis
Biogen 2,978
Large-scale testing (Phase 3)Study completedNCT02587195
What this trial is testing

Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period

Who this might be right for
Multiple Sclerosis
Centre Hospitalier Universitaire de Nice 5
Not applicableStudy completedNCT01881191
What this trial is testing

Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months

Who this might be right for
Multiple Sclerosis
University at Buffalo 50
Early research (Phase 1)Ended earlyNCT02263547
What this trial is testing

Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride

Who this might be right for
Teriflunomide EliminationHealthy Volunteers
Derrick Scott Robertson 14
Not applicableStudy completedNCT03561402
What this trial is testing

Biomarkers and Disease Activity in Patients Treated With Teriflunomide (Aubagio)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
McGill University 24
Early research (Phase 1)Study completedNCT02046629
What this trial is testing

Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers

Who this might be right for
Multiple Sclerosis
Sanofi 12
Large-scale testing (Phase 3)Study completedNCT00134563
What this trial is testing

Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 1,088
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation